Abstract:Background The identification of pathogenic mutations in Alzheimer’s disease (AD) causal genes led to a better understanding of the pathobiology of AD. Familial Alzheimer’s disease (FAD) is known to be associated with mutations in the APP, PSEN1, and PSEN2 genes involved in Aβ production; however, these genetic defects occur in only about 10–20% of FAD cases, and more genes and new mechanism causing FAD remain largely obscure. Methods We performed exome sequencing on family members with a FAD pedigree and identified gene variant ZDHHC21 p.T209S. A ZDHHC21 T209S/T209S knock-in mouse model was then generated using CRISPR/Cas9. The Morris water navigation task was then used to examine spatial learning and memory. The involvement of aberrant palmitoylation of FYN tyrosine kinase and APP in AD pathology was evaluated using biochemical methods and immunostaining. Aβ and tau pathophysiology was evaluated using ELISA, biochemical methods, and immunostaining. Field recordings of synaptic long-term potentiation were obtained to examine synaptic plasticity. The density of synapses and dendritic branches was quantified using electron microscopy and Golgi staining. Results We identified a variant (c.999A > T, p.T209S) of ZDHHC21 gene in a Han Chinese family. The proband presented marked cognitive impairment at 55 years of age (Mini-Mental State Examination score = 5, Clinical Dementia Rating = 3). Considerable Aβ retention was observed in the bilateral frontal, parietal, and lateral temporal cortices. The novel heterozygous missense mutation (p.T209S) was detected in all family members with AD and was not present in those unaffected, indicating cosegregation. ZDHHC21 T209S/T209S mice exhibited cognitive impairment and synaptic dysfunction, suggesting the strong pathogenicity of the mutation. The ZDHHC21 p.T209S mutation significantly enhanced FYN palmitoylation, causing overactivation of NMDAR2B, inducing increased neuronal sensitivity to excitotoxicity leading to further synaptic dysfunction and neuronal loss. The palmitoylation of APP was also increased in ZDHHC21 T209S/T209S mice, possibly contributing to Aβ production. Palmitoyltransferase inhibitors reversed synaptic function impairment. Conclusions ZDHHC21 p.T209S is a novel, candidate causal gene mutation in a Chinese FAD pedigree. Our discoveries strongly suggest that aberrant protein palmitoylation mediated by ZDHHC21 mutations is a new pathogenic mechanism of AD, warranting further investigations for the development of therapeutic interventions.

The role of s-palmitoylation in neurological diseases: implication for zDHHC family

Palmitoylation of synaptic proteins: roles in functional regulation and pathogenesis of neurodegenerative diseases

Control of Mitochondria-Associated Endoplasmic Reticulum Membranes by Protein S-palmitoylation: Novel Therapeutic Targets for Neurodegenerative Diseases.

Mechanism and Function of Dhhc S-Acyltransferases

Protein Palmitoylation and Its Pathophysiological Relevance

Altered Protein Palmitoylation as Disease Mechanism in Neurodegenerative Disorders

The ZDHHC13/ZDHHC17 subfamily: From biological functions to therapeutic targets of diseases

Protein S-Palmitoylation and Lung Diseases

S-Palmitoylation of Synaptic Proteins in Neuronal Plasticity in Normal and Pathological Brains

Palmitoylation regulates myelination by modulating the ZDHHC3-Cadm4 axis in the central nervous system

Function Of Protein S-Palmitoylation In Immunity And Immune-Related Diseases

GCP16 stabilizes the DHHC9 subfamily of protein acyltransferases through a conserved C-terminal cysteine motif

Lipid-induced S-palmitoylation as a Vital Regulator of Cell Signaling and Disease Development.

Exploring the expression patterns of palmitoylating and de-palmitoylating enzymes in the mouse brain using the curated RNA-seq database BrainPalmSeq

S-palmitoylation Regulates AMPA Receptors Trafficking and Function: a Novel Insight into Synaptic Regulation and Therapeutics.

Aberrant palmitoylation caused by a ZDHHC21 mutation contributes to pathophysiology of Alzheimer's disease

Dynamic but discordant alterations in zDHHC5 expression and palmitoylation of its substrates in cardiac pathologies

Deacylases—structure, function, and relationship to diseases

A palmitoyl transferase chemical–genetic system to map ZDHHC-specific S -acylation

Aberrant Palmitoylation Caused by a ZDHHC21 Mutation Contributes to Pathophysiology of Alzheimer’s Disease

Micro-Scale Control of Oligodendrocyte Morphology and Myelination by the Intellectual Disability-Linked Protein Acyltransferase ZDHHC9